IRIS
POZZI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.495
EU - Europa 3.689
AS - Asia 3.422
SA - Sud America 562
Continente sconosciuto - Info sul continente non disponibili 351
AF - Africa 271
OC - Oceania 17
Totale 14.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.338
SG - Singapore 1.221
IT - Italia 1.004
VN - Vietnam 717
CN - Cina 586
RU - Federazione Russa 533
BR - Brasile 442
UA - Ucraina 382
HK - Hong Kong 337
DE - Germania 297
FR - Francia 255
IE - Irlanda 246
FI - Finlandia 226
SE - Svezia 219
CI - Costa d'Avorio 159
DK - Danimarca 140
TR - Turchia 133
GB - Regno Unito 122
IN - India 102
KR - Corea 84
NL - Olanda 79
CA - Canada 69
BD - Bangladesh 56
AT - Austria 51
ZA - Sudafrica 47
AR - Argentina 42
MX - Messico 41
MA - Marocco 29
PL - Polonia 28
ES - Italia 27
IQ - Iraq 22
EC - Ecuador 21
ID - Indonesia 21
JP - Giappone 21
RO - Romania 17
AU - Australia 16
PH - Filippine 15
VE - Venezuela 15
BE - Belgio 13
CL - Cile 13
PK - Pakistan 13
UZ - Uzbekistan 13
CO - Colombia 12
CR - Costa Rica 12
LT - Lituania 12
TH - Thailandia 10
JM - Giamaica 9
SA - Arabia Saudita 9
EG - Egitto 6
JO - Giordania 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
HR - Croazia 5
IL - Israele 5
MY - Malesia 5
PA - Panama 5
PY - Paraguay 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
EU - Europa 4
LB - Libano 4
PE - Perù 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
LC - Santa Lucia 2
SM - San Marino 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
Totale 14.439
Salva come PNG Salva come JPEG
Città #
Ashburn 913
Singapore 747
Dallas 704
Chandler 422
Jacksonville 384
San Jose 342
Council Bluffs 341
Hong Kong 324
Dublin 241
Boardman 237
Ho Chi Minh City 222
Fairfield 204
New York 191
Hanoi 166
Abidjan 159
Wilmington 151
Los Angeles 141
Beijing 130
The Dalles 121
Helsinki 117
Marche 113
Des Moines 99
Lauterbourg 99
Houston 87
Moscow 85
Seattle 85
Lawrence 84
Princeton 83
San Mateo 80
Milan 76
Munich 74
Ancona 73
Ann Arbor 69
Orem 64
Woodbridge 62
Hefei 60
Cambridge 59
Turin 53
Buffalo 44
Da Nang 44
Turku 39
Chennai 38
Centro 37
Chicago 37
Haiphong 36
San Diego 36
São Paulo 36
Vienna 34
Santa Clara 31
Shanghai 30
Amsterdam 29
Johannesburg 29
London 27
Tolentino 27
Recanati 26
Montreal 25
Rome 25
Stockholm 23
Brooklyn 22
Washington 22
Denver 21
Nuremberg 21
Wuhan 20
Mexico City 18
Tokyo 18
Atlanta 17
Warsaw 17
Redmond 16
Ankara 15
Berlin 15
Boston 15
Manchester 15
Aversa 14
Guangzhou 14
Poplar 14
Belo Horizonte 13
Brussels 13
Curitiba 13
Pavia 13
Phoenix 13
Brasov 12
Frankfurt am Main 12
Iesi 12
Biên Hòa 11
Hải Dương 11
Naples 11
Quito 11
Rio de Janeiro 11
San Francisco 11
Tashkent 11
Civitanova Marche 10
Mumbai 10
Pune 10
Salt Lake City 10
San José 10
Toronto 10
Wuxi 10
Baghdad 9
Delhi 9
Istanbul 9
Totale 8.884
Salva come PNG Salva come JPEG
Nome #
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 215
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 208
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 199
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 182
Clinical performance and utility of a NNMT-based urine test for bladder cancer 181
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 179
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 177
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 175
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 173
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 173
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 172
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 171
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 168
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 165
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 165
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 162
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 160
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 160
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 160
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 159
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 158
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 157
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 156
Involvement of the oral cavity in psoriasis: results of a clinical study 156
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 156
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 154
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 154
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 151
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 151
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 150
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 149
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 148
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 146
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 145
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 141
Inflammatory cytokines pattern in recurrent miscarriage. 140
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 140
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 139
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 138
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 135
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 135
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 135
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 134
Paraoxonase-2 expression in oral squamous cell carcinoma 130
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 129
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 128
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 128
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 128
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 128
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 126
CSCs selection, characterization and tumorigenic potential in OSCC. 123
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 123
Inflammatory cytokines pattern in recurrent miscarriage. 122
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 122
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 121
FTIR Imaging as a new tool for investigating oral tongue squamous cell carcinoma 121
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 121
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 121
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 121
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 121
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 120
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 120
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 119
Catecholamine O-Methyltransferase as a Promising Diagnostic and Therapeutic Target in Oral Squamous Cell Carcinoma 119
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 117
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 117
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 117
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 116
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 115
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 114
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 114
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 113
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 113
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 112
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 108
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 108
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 106
Enhanced expression of paraoxonase 2 in human bladder cancer 106
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 105
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 105
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 103
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 103
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 101
Paraoxonase 2 (PON2) expression in bladder cancer 100
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 99
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 97
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 97
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 97
Urinary Cell-Free DNA as a potential diagnostic biomarker for bladder cancer in older adults 96
Espressione di Pokemon nel carcinoma orale. 95
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 95
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 94
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 94
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 93
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 92
The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study 91
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 91
Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma 90
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 90
Totale 13.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022599 0 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/20252.146 287 144 101 46 108 30 185 74 400 153 251 367
2025/20266.599 540 382 734 658 711 433 1.129 555 531 541 185 200
2026/2027470 274 196 0 0 0 0 0 0 0 0 0 0
Totale 14.807